9-136763873-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000316144.6(LCN15):c.233C>T(p.Pro78Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000434 in 1,613,508 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000316144.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCN15 | NM_203347.2 | c.233C>T | p.Pro78Leu | missense_variant | 2/7 | ENST00000316144.6 | NP_976222.1 | |
LCN15 | XM_011518672.2 | c.104C>T | p.Pro35Leu | missense_variant | 2/7 | XP_011516974.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCN15 | ENST00000316144.6 | c.233C>T | p.Pro78Leu | missense_variant | 2/7 | 1 | NM_203347.2 | ENSP00000313833.5 | ||
LCN15 | ENST00000482511.1 | n.2383C>T | non_coding_transcript_exon_variant | 1/6 | 1 | |||||
LCN15 | ENST00000495223.1 | n.165C>T | non_coding_transcript_exon_variant | 2/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000299 AC: 75AN: 250796Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135602
GnomAD4 exome AF: 0.000446 AC: 652AN: 1461244Hom.: 1 Cov.: 33 AF XY: 0.000448 AC XY: 326AN XY: 726920
GnomAD4 genome AF: 0.000315 AC: 48AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74450
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at